PT-141: Complete Guide to the Brain-Based Libido Peptide

PT-141 (Bremelanotide) is the first FDA-approved treatment targeting sexual desire in the brain rather than blood flow. This guide covers mechanisms, protocols, male and female applications, and combination strategies.